IDeAl External Advisory Board
The Advisory Board consists of representatives and stakeholders for small population groups, selected of different research areas as well as from regions from all over the world. The Advisory Board has a consultative function and multiplies and translates information related to the IDEAL activities in small population group trials. The Advisory Board also provides contact to experts and industry in Europe and the world as well as to relevant stakeholders, e.g. EURORDIS, and therefore assists in distributing approved project results to the scientific community. The current members of the IDeAl External Advisory Board are
- Aymé, Ségolène, FR, Director of Orphanet
- Burzykowski, Tomasz, BE, Vice President of Research at IDDI Inc.
- Forster, Martin, UK, Health Economist at University of York
- Herold, Ralf, UK, Senior Scientific Officier at EMA
- Jennison, Christopher, UK, Professor of Statistics at University of Bath
- Julious, Steven, UK, Professor of Medical Statistics at University of Sheffield
- Nguyen, Gerard, FR, Member and Former President of Rett Syndrom Europe
- Pertile, Paolo, IT, Associate Professor of Public Finance at Universitá de Verona
- Rosenberger, William, USA, Professor of Statistics at George Mason University
- Wassmer, Gernot, DE, Chief Software Architect at ICON
- Sabatti, Chiara, USA, Associate Professor of Statistics and Associate Professor of Biomedical Data Science at Stanford University
- Pons, Gerard, FR, Member of the EMA Paediatric Committee and Vice President of the EMA Extrapolation Working group
- Baroldi, Paolo, I, Chief Medical Officer at VANDA Pharmaceuticals
- Bretz, Frank, CH, Global Head of the Statistical Methodology Group at Novartis
- Bailey, Rosemary, UK, Professor Emerita of Design of Experiments at Queen Mary University of London
- Schmalzing, Günther, DE, Head of Molecular Pharmacology at RWTH Aachen University.